Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K /Akt pathway-Reference-Cited by-同舟云学术

Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K /Akt pathway

Published:2021-07-22 Issue:11 Volume:36 Page:2186-2195
ISSN:1520-4081
Container-title:Environmental Toxicology
language:en
Short-container-title:Environmental Toxicology

Author:

Kao Chien‐Chang¹²,Cheng Yi‐Ching³,Yang Ming‐Hsin²,Cha Tai‐Lung²,Sun Guang‐Huan²,Ho Chi‐Tang⁴,Lin Ying‐Chao⁵⁶⁷,Wang Hao‐Kuang⁸⁹,Wu Sheng‐Tang²,Way Tzong‐Der³¹⁰¹¹^ORCID

Affiliation:

1. Graduate Institute of Medical Sciences National Defense Medical Center Taipei Taiwan

2. Division of Urology, Department of Surgery Tri‐Service General Hospital, National Defense Medical Center Taipei Taiwan

3. Department of Biological Science and Technology College of Life Sciences, China Medical University Taichung Taiwan

4. Department of Food Science Rutgers University New Brunswick New Jersey USA

5. Division of Neurosurgery Buddhist Tzu Chi General Hospital Taichung Taiwan

6. School of Medicine Tzu Chi University Hualien Taiwan

7. Department of Medical Imaging and Radiological Science Central Taiwan University of Science and Technology Taichung Taiwan

8. Department of Neurosurgery E‐Da Hospital/I‐Shou University Kaohsiung Taiwan

9. School of Medicine I‐Shou University Kaohsiung Taiwan

10. Ph.D. Program for Biotechnology Industry College of Life Sciences, China Medical University Taichung Taiwan

11. Department of Health and Nutrition Biotechnology Asia University Taichung Taiwan

Funder

China Medical University

ASCRS Research Foundation

Tri-Service General Hospital

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/tox.23332

Reference36 articles.

1. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006

2. Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy

3. NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer

4. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10

2. Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies;Journal of Hematology & Oncology;2024-09-04

3. Exploring the Targets and Molecular Mechanisms of Curcumin for the Treatment of Bladder Cancer Based on Network Pharmacology, Molecular Docking and Molecular Dynamics;Molecular Biotechnology;2024-06-01

4. Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential;Phytomedicine;2024-05

5. Exploring the Role of ENO1 in Regulating Cell Proliferation and Cell Cycle in Hepatocellular Carcinoma: Insights from Proteomic Analysis;2024-04-22